Detalles de la búsqueda
1.
Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.
Epilepsia;
58(9): 1533-1541, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28681418
2.
Challenges of Developing an Observable Parent-Reported Measure: A Qualitative Study of Functional Impact of ADHD in Children.
Value Health;
20(6): 828-833, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577701
3.
Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder.
Health Econ;
26(11): 1459-1466, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27620206
4.
Estimating minimal important differences for several scales assessing function and quality of life in patients with attention-deficit/hyperactivity disorder.
CNS Spectr;
22(1): 31-40, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27535815
5.
PRISM, a Patient-Reported Outcome Instrument, Accurately Measures Symptom Change in Refractory Gastroesophageal Reflux Disease.
Dig Dis Sci;
62(3): 593-606, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28116591
6.
Developing a Risk Score to Guide Individualized Treatment Selection in Attention Deficit/Hyperactivity Disorder.
Value Health;
18(6): 824-31, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26409610
7.
Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument.
Health Qual Life Outcomes;
13: 133, 2015 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26297205
8.
Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder.
Health Qual Life Outcomes;
13: 184, 2015 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26577642
9.
Development and validation of algorithms to identify acute diverticulitis.
Pharmacoepidemiol Drug Saf;
24(1): 27-37, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25257514
10.
Development and validation of a disease-targeted quality of life instrument for chronic diverticular disease: the DV-QOL.
Qual Life Res;
24(1): 163-79, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25059533
11.
Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case.
Eur Child Adolesc Psychiatry;
23(7): 587-98, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24166532
12.
Increased risk for irritable bowel syndrome after acute diverticulitis.
Clin Gastroenterol Hepatol;
11(12): 1614-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23524129
13.
Long-term risk of acute diverticulitis among patients with incidental diverticulosis found during colonoscopy.
Clin Gastroenterol Hepatol;
11(12): 1609-13, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23856358
14.
Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.
Value Health;
15(6): 940-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22999145
15.
Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
Pharmacoepidemiol Drug Saf;
21 Suppl 2: 130-7, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22552988
16.
Treatment persistence & health care costs of adult MDD patients treated with escitalopram vs. citalopram in a medicaid population.
Manag Care;
21(1): 49-58, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22332457
17.
Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
Ann Pharmacother;
45(4): 441-51, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21415162
18.
Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States.
Clin Ther;
31(3): 644-56, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19393855
19.
Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs.
J Med Econ;
12(2): 124-35, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19566483
20.
Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control.
Neuropsychiatr Dis Treat;
13: 443-455, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28243096